Difference between revisions of "Team:MIT"
| Line 42: | Line 42: | ||
<ul class="img-home"> | <ul class="img-home"> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:MIT/ | + | <a href="https://2016.igem.org/Team:MIT/Diagnosis_and_Future_Implications"> |
<img src="https://static.igem.org/mediawiki/2016/6/64/T--MIT--FutureButton.svg" alt="Future work, designs, and collaborations" > | <img src="https://static.igem.org/mediawiki/2016/6/64/T--MIT--FutureButton.svg" alt="Future work, designs, and collaborations" > | ||
<span class="text-content"><span><br><br><br><br><br><br><br><br><br><br><br><br><br><br>Read more about the future of our work through circuit design, clinical application, and iGEM collaborations<br><br></span></span> | <span class="text-content"><span><br><br><br><br><br><br><br><br><br><br><br><br><br><br>Read more about the future of our work through circuit design, clinical application, and iGEM collaborations<br><br></span></span> | ||
Revision as of 01:57, 17 October 2016
This diagnostic process can be expedited by using the following synthetic biological tools to sense molecular markers in endometrial biopsy samples.
-
Respond to malfunctioning of hormone sensing in endometriosis
Read more
-
Identify cells in disease state through dysregulated miRNA activity
Read more
-
Give the circuit a form of memory through a biological latch system
Read more
